Immunogenicity, safety and consistency of seven lots of an inactivated COVID-19 vaccine in healthy children and adolescents: a randomized, double-blind, controlled, phase IV clinical trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Weijun,Hu

第一单位： Institute of Immunization Program, Shaanxi Provincial Center for Disease Control and Prevention, Xi'an, China.

作者： Weijun,Hu ^[1] ; Xiaoyu,Liu ^[1] ; Xi,Lu ^[2] ; Dan,Zhang ^[1] ; Shuo,Liu ^[3] ; Xianjin,Gu ^[4] ; Dan,Liu ^[4] ; Jianwen,Sun ^[5] ; Tiantian,Zhou ^[1] ; Xinge,Li ^[3] ; Yongjun,Gao ^[2] ; Yanwei,Zhao ^[5] ; Guoliang,Cui ^[6] ; Shaobai,Zhang ^[1]

作者单位： Institute of Immunization Program, Shaanxi Provincial Center for Disease Control and Prevention, Xi'an, China. ^[1] Medical Affairs Department, Sinovac Biotech Co., Ltd., Beijing, China. ^[2] Clinical Research and Development Center, Sinovac Biotech Co., Ltd., Beijing, China. ^[3] Department of Immunization Program, Yanliang District Center for Disease Control and Prevention, Xi'an, China. ^[4] Medical Affairs Department, Sinovac Life Sciences Co., Ltd., Beijing, China. ^[5] Quality Assurance Department, Sinovac Life Sciences Co., Ltd., Beijing, China. ^[6]

关键词 CoronaVac children and adolescents immunogenicity lot-to-lot consistency safety

主题词儿童(Child);人类(Humans);青少年(Adolescent);抗体, 中和(Antibodies, Neutralizing);双盲法(Double-Blind Method)

DOI 10.3389/fimmu.2023.1320352

PMID 38250072

发布时间 2024-04-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交